CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor

Seminars in Immunology

Volumn 10, Issue 4, 1998, Pages 287-297

  Sato, Shinichi ^a   Tuscano, Joseph M ^b   Inaoki, Makoto ^c   Tedder, Thomas F ^c  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; CD22; CD22 deficient mice; SHP1; Signal transduction; Vav

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD22 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032147065     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0121     Document Type: Article

References (57)

1. 1. Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 15:481-504
2. 2. Cyster JG, Goodnow CC (1997) Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment. Immunity 6:509-517
3. 3. Erickson LD, Tygrett LT, Bhatia SK, Grabstein KH, Waldschmidt TJ (1996) Differential expression of CD22 (Lyb8) on murine B cells. Int Immunol 8:1121-1129
4. 4. Stoddart A, Ray RJ, Paige CJ (1997) Analysis of murine CD22 during B cell development - CD22 is expressed on B cell progenitors prior to IgM. Int Immunol 9:1571-1579
5. 5. Dörken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM (1986) HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136:4470-4479
6. 6. Wilson GL, Fox CH, Fauci AS, Kehrl JH (1991) cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions. J Exp Med 173:137-146
7. 7. Engel P, Nojima Y, Roth stein D, Zhou L-J, Wilson GL, Kehrl JH, Tedder TF (1993) The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes. J Immunol 150:4719-4732
8. 8. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, de Bellard M-E, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR (1994) Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4:965-972
9. 9. Engel P, Wagner N, Miller A, Tedder TF (1995) Identification of the ligand binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med 181:1581-1586
10. 10. Torres RM, Law C-L, Santos-Argumedo L, Kirkham PA, Grabstein K, Parkhouse RME, Clark EA (1992) Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule. J Immunol 149:2641-2649
11. 11. Law C-L, Aruffo A, Chandran KA, Doty RT, Clark EA (1995) Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J Immunol 155:3368-3376
12. 12. Schulte RJ, Campbell M-A, Fischer WH, Sefton BM (1992) Tyrosine phosphorylation of CD22 during B cell activation. Science 258:1001-1004
13. 13. Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA (1993) CD22 associates with the human surface IgM-B cell antigen receptor complex. Proc Natl Acad Sci USA 90:3236-3240
14. 14. Tuscano JM, Engel P, Tedder TF, Agarwal A, Kehrl JH (1996) Involvement of p72syk kinase, p53/561yn kinase and phosphatidyl inositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur J Immunol 26:1246-1252
15. 15. Peaker CJG, Neuberger MS (1993) Association of CD22 with the B cell antigen receptor. Eur J Immunol 23:1358-1363
16. 16. Shen SH, Bastien L, Posner BI, Chretien P (1991) A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature 352:736-739
17. 17. Matthews RJ, Bowne DB, Flores E, Thomas ML (1992) Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol 12:2396-2405
18. 18. Plutzky J, Neel BG, Rosenberg RD (1992) Isolation of a src homology 2-containing tyrosine phosphatase. Proc Natl Acad Sci USA 89:1123-1127
19. 19. Doody GM, Justement LB, Delibrias CC, Mathews RJ, Lin J, Thomas ML, Fearon DT (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242-244
20. 20. Campbell MA, Klinman NR (1995) Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol 25:1573-1579
21. 21. Lankester AC, van Schijndel GM, van Lier RA (1995) Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligation. J Biol Chem 270:20305-20308
22. γ1 upon B cell activation. J Exp Med 183:547-560
23. 23. Sato S, Jansen PJ, Tedder TF (1997) CD19 and CD22 reciprocally regulate Vav tyrosine phosphorylation during B lymphocyte signaling. Proc Natl Acad Sci USA 94:13158-13162
24. 24. Tooze RM, Doody GM, Fearon DT (1997) Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59-67
25. 25. Tuscano J, Engel P, Tedder TF, Kehrl JH (1996) Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation. Blood 87:4723-4730
26. 26. Pezzutto A, Dörken B, Moldenhauer G, Clark EA (1987) Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. J Immunol 138:98-103
27. 27. Pezzutto A, Rabinovitch PS, Dörken B, Moldenhauer G, Clark EA (1988) Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol 140:1791-1795
28. 28. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang MLK, Tedder TF (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551-562
29. 29. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law C-L, Clark EA (1996) CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384:634-637
30. 30. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC (1997) CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 7:133-143
31. 31.O'Keefe TL, Williams GT, Davies SL, Neuberger MS (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274:798-801
32. 32. Cyster JG, Goodnow CC (1995) Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 2:13-24
33. 33. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, Tedder TF (1995) Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39-50
34. 34. Sato S, Steeber DA, Jansen PJ, Tedder TF (1997) CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J Immunol 158:4662-4669
35. 35. Sato S, Steeber DA Tedder TF (1995) The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92:11558-11562
36. 36. Schultz LD, Schweitzer PA, Ranjan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR (1993) Mutations at the murine motheaten locus are within the hematopoietic cell proteintyrosine phosphatase (Hcph) gene. Cell 73:1445-1454
37. 37. Tsui HW, Siminovitch KA de Souza L, Tsui FWL (1993) Motheaten and viable motheaten mice have mutations in the hemopoietic cell phosphatase gene. Nature Genet 4:124-129
38. 38. Pani G, Kozlowski M, Gambier JC, Mills GB, Siminovitch KA (1995) Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling. J Exp Med 181:2077-2084
39. 39. Sidman CL, Shultz LD, Unanue ER (1978) The mouse mutant 'Motheaten'. Functional studies of the immune system. J Immunol 121:2399-2404
40. 40. van Oers NSC, Tao W, Watts JD, Johnson P, Aebersold R, Teh A-S (1993) Constitutive tyrosine phosphorylation of the T cell receptor (TCR) ζ subunit: regulation of TCR-associated tyrosine kinase activity by TCRζ. Mol Cell Biol 13:5771-5780
41. 41. Nadler MJS, McLean PA, Neel BG, Wortis HH (1997) B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines. J Immunol 159:4233-4243
42. 42. Scharenberg AM, Kinet J-P (1996) The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 87:961-964
43. 43. Rigley KP, Harnett MM, Klaus GGB (1989) Co-cross-linking of surface immunoglobulin Fc gamma receptors on B lymphocytes uncouples the antigen receptors from their associated G protein. Eur J Immunol 19:481-485
44. 44. Rijkers GT, Griffioen AW, Zegers BJM, Gambier JC (1990) Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95. Proc Natl Acad Sci USA 87:8766-8770
45. 2+]i is not sufficient and protein kinase C activation is not required for these pathways of surface IgM-mediated desensitization. J Immunol 147:1739-1745
46. 46. Bustelo XR, Barbacid M (1992) Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256:1196-1199
47. 47. Deckert M, Tertare-Deckert S, Couture C, Mustelin T, Altman A (1996) Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591-604
48. 48. Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355
49. 49. Tarakhovsky A, Turner M, Shaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz V (1995) Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374:467-470
50. 50. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W (1995) Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-473
51. 51. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF (1996) CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol 156:4371-4378
52. 52. Chalupny NJ, Kanner SB, Schieven GL, Wee S, Gilliland LK, Aruffo A, Ledbetter JA (1993) Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J 12:2691-2696
53. 53. Uckun FM, Burkhardt AL, Jarvis L, Jun X, Stealey B, Dibirdik I, Myers DE, Tuel-Ahlgren L, Bolen JB (1993) Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J Biol Chem 268:21772-21184
54. 54. Weng WK, Jarvis L, LeBien TW (1994) Signaling through CD19 activates vav/mitogen-activated protein kinase pathway and induces formation of a CD19/vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 269:32514-32521
55. 55. Kon-Kozlowski M, Pani G, Pawson T, Siminovitch KA (1996) The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem 271:3856-3862
56. 56. Collins TL, Deckert M, Altman A (1997) Views of Vav. Immunol Today 18:221-225
57. 57. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR (1997) Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the Vav proto-oncogene product. Nature 385:169-172